>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
运动疗法治疗癌症恶病质的研究进展
作者:周昊鹏1  杭珉叶2  秦艺璇3  王芊芊4  刘芳5 
单位:1. 江苏大学 医学院, 江苏 镇江 212013;
2. 南京中医药大学 针灸推拿学院, 江苏 南京 210029;
3. 天津医科大学 公共卫生学院, 天津 300070;
4. 天津中医药大学 中医学院, 天津 301617;
5. 江苏大学 国际基因组学研究中心, 江苏 镇江 212013
关键词:癌症恶病质 肺康复 运动疗法 综述 
分类号:R730.5
出版年·卷·期(页码):2023·42·第六期(965-968)
摘要:

癌症恶病质是以全身炎症、骨骼肌大量消耗和体重减轻为特征的多器官综合征。迄今,癌症恶病质的药物治疗和营养支持虽有一定疗效,但不能有效逆转其恶性结局。现有证据表明,运动疗法有助于逆转癌症恶病质进展,并抑制患者体重减轻及提高生活质量。作者综述了运动疗法治疗癌症恶病质的有效性、安全性、潜在机制和生物标志物,以期为精准治疗癌症恶病质带来新的愿景。

参考文献:

[1] ROCH B,COFFY A,JEAN-BAPTISTE S,et al.Cachexia-sarcopenia as a determinant of disease control rate and survival in non-small lung cancer patients receiving immune-checkpoint inhibitors[J].Lung Cancer,2020,143:19-26.
[2] MUSCARITOLI M,LUCIA S,FARCOMENI A,et al.Prevalence of malnutrition in patients at first medical oncology visit:the PreMiO study[J].Oncotarget,2017,8(45):79884-79896.
[3] KICHENADASSE G,MINERS J O,MANGONI A A,et al.Association between body mass index and overall survival with immune checkpoint inhibitor therapy for advanced non-small cell lung cancer[J].JAMA Oncol,2020,6(4):512-518.
[4] FONSECA G W P D,FARKAS J,DORA E,et al.Cancer cachexia and related metabolic dysfunction[J].Int J Mol Sci,2020,21(7):2321.
[5] BABA M R,BUCH S A.Revisiting cancer cachexia:pathogenesis,diagnosis,and current treatment approaches[J].Asia Pac J Oncol Nurs,2021,8(5):508-518.
[6] NORDHAUSEN K,SOLASS W,DEMTROEDER C,et al.Cachexia-anorexia syndrome in patients with peritoneal metastasis:an observational study[J].Pleura Peritoneum,2016,1(1):57-63.
[7] CHAN G C,THAN W H,KWAN B C,et al.Adipose and serum zinc alpha-2-glycoprotein(ZAG) expressions predict longitudinal change of adiposity,wasting and predict survival in dialysis patients[J].Sci Rep,2022,12(1):9087.
[8] CERO C,LEA H J,ZHU K Y,et al.β3-Adrenergic receptors regulate human brown/beige adipocyte lipolysis and thermogenesis[J].JCI Insight,2021,6(11):e139160.
[9] RUPERT J E,NARASIMHAN A,JENGELLEY D H A,et al.Tumor-derived IL-6 and trans-signaling among tumor,fat,and muscle mediate pancreatic cancer cachexia[J].J Exp Med,2021,218(6):e20190450.
[10] ARMSTRONG V S,FITZGERALD L W,BATHE O F.Cancer-associated muscle wasting-candidate mechanisms and molecular pathways[J].Int J Mol Sci,2020,21(23):9268.
[11] FANG W Y,TSENG Y T,LEE T Y,et al.Triptolide prevents LPS-induced skeletal muscle atrophy via inhibiting NF-κB/TNF-α and regulating protein synthesis/degradation pathway[J].Br J Pharmacol,202,178(15):2998-3016.
[12] WANG F,LIU H,HU L,et al.The Warburg effect in human pancreatic cancer cells triggers cachexia in athymic mice carrying the cancer cells[J].BMC Cancer,2018,18(1):360.
[13] BARREIRA J.The role of nutrition in cancer patients[J].Nutr Cancer,2021,73(11-12):2849-2850.
[14] CLEMENTE-SUÁREZ V,REDONDO-FLÓREZ L,RUBIO-ZARAPUZ A,et al.Nutritional and exercise interventions in cancer-related cachexia:an extensive narrative review[J].Int J Environ Res Public Health,2022,19(8):4604.
[15] MORIGNY P,BOUCHER J,ARNER P,et al.Lipid and glucose metabolism in white adipocytes:pathways,dysfunction and therapeutics[J].Nat Rev Endocrinol,2021,17(5):276-295.
[16] BINNS C,LEE M,LEE A.Problems and prospects:public health regulation of dietary supplements[J].Annu Rev Public Health,2018,39:403-420.
[17] MOCHAMA T,CUHLS H,MARINOVA M,et al.A systematic review on the role of vitamins,minerals,proteins,and other supplements for the treatment of cachexia in cancer:a European Palliative Care Research Centre cachexia project[J].J Cachexia Sarcopenia Muscle,2017,8(1):25-39.
[18] HANNA R,GHOBRY L,WASSEF O,et al.A practical approach to nutrition,protein-energy wasting,sarcopenia,and cachexia in patients with chronic kidney disease[J].Blood Purif,2020,49(1-2):202-211.
[19] BARREA L,CAPRIO M,TUCCINARDI D,et al.Could ketogenic diet "starve" cancer? Emerging evidence[J].Crit Rev Food Sci Nutr,2022,62(7):1800-1821.
[20] 周昊鹏,苏兆亮,刘芳.肺癌恶病质的发病机制和临床治疗进展[J/OL].江苏大学学报(医学版):1-10.https://doi.org/10.13312/j.issn.1671-7783.y220155.
[21] SANTOS J,COSTA A,DIAS T,et al.Towards drug repurposing in cancer cachexia:potential targets and candidates[J].Pharmaceuticals,2021,14(11):1084.
[22] ZHU C,MA H,HE A,et al.Exercise in cancer prevention and anticancer therapy:efficacy,molecular mechanisms and clinical information[J].Cancer Lett,2022,544:215814.
[23] KONOPKA A R,HARBER M P.Skeletal muscle hypertrophy after aerobic exercise training[J].Exerc Sport Sci Rev,2014,42(2):53-61.
[24] HARDEE J P,MONTALVO R N,CARSON J A.Linking cancer cachexia-induced anabolic resistance to skeletal muscle oxidative metabolism[J].Oxid Med Cell Longev,2017,2017:8018197.
[25] BALLARÒ R,PENNA F,PIN F,et al.Moderate exercise improves experimental cancer cachexia by modulating the redox homeostasis[J].Cancers,2019,11(3):285.
[26] MADDOCKS M,JONES L,WILCOCK A.Immunological and hormonal effects of exercise:implications for cancer cachexia[J].Curr Opin Support Palliat Care,2013,7(4):376-382.
[27] GRANDE A J,SILVA V,SAWARIS NETO L,et al.Exercise for cancer cachexia in adults[J].Cochrane Database Syst Rev,2021,3(3):CD010804.
[28] GHOLAMIAN S,ATTARZADEH H,RASHIDLAMIR A,et al.The effects of interval aerobic training on mesenchymal biomarker gene expression,the rate of tumor volume,and cachexia in mice with breast cancer[J].Iran J Basic Med Sci,2020,23(2):244-250.
[29] RODRIGUEZ A L,WHITEHURST M,FICO B G,et al.Acute high-intensity interval exercise induces greater levels of serum brain-derived neurotrophic factor in obese individuals[J].Exp Biol Med,2018,243(14):1153-1160.
[30] PAPADOPOULOS E,SANTA MINA D.Can we HIIT cancer if we attack inflammation?[J].Cancer Causes Control,2018,29(1):7-11.
[31] NIELS T,TOMANEK A,SCHNEIDER L,et al.Exercise improves patient outcomes in advanced pancreatic cancer patient during medical treatment[J].Pancreat Disord Ther,2018,8:193.
[32] AHMADABADI F,SAGHEBJOO M,HUANG C J,et al.The effects of high-intensity interval training and saffron aqueous extract supplementation on alterations of body weight and apoptotic indices in skeletal muscle of 4T1 breast cancer-bearing mice with cachexia[J].Appl Physiol Nutr Metab,2020,45(5):555-563.
[33] TSUJI K,MATSUOKA Y,OCHI E.High-intensity interval training in breast cancer survivors:a systematic review[J].BMC Cancer,2021,21(1):184.
[34] KAMEL F H,BASHA M A,ALSHARIDAH A S,et al.Resistance training impact on mobility,muscle strength and lean mass in pancreatic cancer cachexia:a randomized controlled trial[J].Clin Rehabil,2020,34(11):1391-1399.
[35] CAPOZZI L C,MCNEELY M L,LAU H Y,et al.Patient-reported outcomes,body composition,and nutrition status in patients with head and neck cancer:results from an exploratory randomized controlled exercise trial[J].Cancer,2016,122(8):1185-1200.
[36] SCHINK K,GANER H,RELJIC D,et al.Assessment of gait parameters and physical function in patients with advanced cancer participating in a 12-week exercise and nutrition programme:a controlled clinical trial[J].Eur J Cancer Care,2020,29(2):e13199.
[37] ARGILÉS J M,LÓPEZ-SORIANO F J,STEMMLER B,et al.Novel targeted therapies for cancer cachexia[J].Biochem J,2017,474(16):2663-2678.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 414587 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364